CRUSE MICHAEL (Senior VP, Corporate Operation) purchased 2.50K shares of ONKURE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $18.6K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/26/2021ACC: 0001209191-21-053520
Officer· Senior VP, Corporate Operation
Since Apr 2021
+2.50K
Net shares
Net buyer
$18.6K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
2.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2.50K
Price / share
$7.45
Trade value
$18.62K
% of position
New position
8/25/2021
0.00→2.50K
Total
Net shares
+2.50K
Net value
$18.62K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/25/2021 | P · Purchase | +2.50K | $7.45 | $18.62K | New position | 0.00 | 2.50K |
| Total | +2.50K | $18.62K | ||||||
Derivative Transactions0
No derivative transactions reported